NEUROBO PHARMACEUTICALS INC's ticker is and the CUSIP is 64132R206. A total of 18 filers reported holding NEUROBO PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 841,815 | $604,002 | 0.53% |
| CVI Holdings, LLC | 215,045 | $154,295 | 0.02% |
| Engineers Gate Manager LP | 19,693 | $14,130 | 0.00% |
| Walleye Capital LLC | 95,000 | $68,163 | 0.00% |
| Kingsview Wealth Management, LLC | 17,839 | $12,799 | 0.00% |
| Virtu Financial LLC | 13,953 | $10 | 0.00% |
| UBS Group AG | 3,627 | $2,611 | 0.00% |
| Squarepoint Ops LLC | 24,146 | $17,325 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 65,035 | $46,663 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 8 | $6 | 0.00% |